-+ 0.00%
-+ 0.00%
-+ 0.00%

MOLECULIN ANNOUNCES COMPLETION OF TREATMENT FOR THE 45 PATIENTS IN PIVOTAL “MIRACLE” PHASE 3 AML TRIAL ON PACE FOR Q1 2026

Reuters·12/09/2025 13:07:00

Please log in to view news